The Wnt signalling pathway is upregulated in an in vitro model of acquired tamoxifen resistant breast cancer. - Wikidata - awgldk - TriplyDB

The Wnt signalling pathway is upregulated in an in vitro model of acquired tamoxifen resistant breast cancer.

The Wnt signalling pathway is upregulated in an in vitro model of acquired tamoxifen resistant breast cancer.

http://www.wikidata.org/entity/Q34644859

about

TWIST1 and BMI1 in Cancer Metastasis and Chemoresistance Role of microRNAs in chemoresistance Epithelial-Mesenchymal Transition and Breast Cancer CCNA2 is a prognostic biomarker for ER+ breast cancer and tamoxifen resistance The Genetic Architecture of Murine Glutathione Transferases Reconstruction of temporal activity of microRNAs from gene expression data in breast cancer cell line.New targeted therapies for breast cancer: A focus on tumor microenvironmental signals and chemoresistant breast cancers Prediction of signaling cross-talks contributing to acquired drug resistance in breast cancer cells by Bayesian statistical modeling Acquisition of resistance to trastuzumab in gastric cancer cells is associated with activation of IL-6/STAT3/Jagged-1/Notch positive feedback loop MicroRNA networks regulated by all-trans retinoic acid and Lapatinib control the growth, survival and motility of breast cancer cells Computational Identification of Key Regulators in Two Different Colorectal Cancer Cell Lines.Bayesian model of signal rewiring reveals mechanisms of gene dysregulation in acquired drug resistance in breast cancer Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion.Migration and invasion is inhibited by silencing ROR1 and ROR2 in chemoresistant ovarian cancer.Macrophages mediate a switch between canonical and non-canonical Wnt pathways in canine mammary tumors.Breast Cancer Stem-Like Cells Are Inhibited by Diosgenin, a Steroidal Saponin, by the Attenuation of the Wnt β-Catenin Signaling via the Wnt Antagonist Secreted Frizzled Related Protein-4.Prostate apoptosis response 4 (PAR4) expression modulates WNT signaling pathways in MCF7 breast cancer cells: A possible mechanism underlying PAR4-mediated docetaxel chemosensitivity.Emerging strategies to overcome resistance to endocrine therapy for breast cancer.The roles of AXIN2 in tumorigenesis and epigenetic regulation.Targeting the androgen receptor in breast cancer.Comment on: Wnt5a inhibited human trophoblast cell line HTR8/SVneo invasion: implications for early placentation and preeclampsia.Wnt/Glycogen Synthase Kinase 3β/β-catenin Signaling Activation Mediated Sevoflurane Preconditioning-induced Cardioprotection.Upregulated PFTK1 promotes tumor cell proliferation, migration, and invasion in breast cancer.A83-01 inhibits TGF-β-induced upregulation of Wnt3 and epithelial to mesenchymal transition in HER2-overexpressing breast cancer cells.Noncoding RNAs in Cancer Cell Plasticity.Zbed3 contributes to malignant phenotype of lung cancer via regulating β-catenin and P120-catenin 1.Expression of the novel Wnt receptor ROR2 is increased in breast cancer and may regulate both β-catenin dependent and independent Wnt signalling.Exosomes from docetaxel-resistant breast cancer cells alter chemosensitivity by delivering microRNAs.Epigallocatechin gallate inhibits the growth of MDA-MB-231 breast cancer cells via inactivation of the β-catenin signaling pathway.Endocrine Therapy of Estrogen Receptor-Positive Breast Cancer Cells: Early Differential Effects on Stem Cell Markers.Exome-capture RNA sequencing of decade-old breast cancers and matched decalcified bone metastases Evaluation of expression of the Wnt signaling components in canine mammary tumors via RT2 Profiler PCR Array and immunochemistry assays.Overcoming Resistance to Endocrine Therapy in Breast Cancer: New Approaches to a Nagging Problem.Dually modified transmembrane proteoglycans in development and disease.Elevated CRB3 expression suppresses breast cancer stemness by inhibiting β-catenin signalling to restore tamoxifen sensitivity.Exposure to sub-lethal dose of a combination insecticide during early embryogenesis influences the normal patterning of mesoderm resulting in incomplete closure of ventral body wall of chicks of domestic hen.Proteomics analysis of malignant and benign prostate tissue by 2D DIGE/MS reveals new insights into proteins involved in prostate cancer.Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1.The expression of β-catenin in different subtypes of breast cancer and its clinical significance.Casein kinase 1α: biological mechanisms and theranostic potential.

P2860

Q26744196-7C7AA69A-C1C9-46A6-8ECA-BB27EC39DD86 Q26770485-6319ABCD-E4FE-4C5F-85AD-E3F23890A6AB Q26773055-83A06CBF-E5F8-4ED7-826D-E8C0F186E77A Q28540790-B1D40693-9882-4584-A53B-59C0A8C1A207 Q28553004-53FE160D-1B55-401E-8C6B-14B0871EB1AD Q31036763-0E8B6C25-DC98-477B-82A3-C53B429005A5 Q34706060-6EBA208B-DD7D-4D99-97BF-6DDE9387D239 Q35544606-DFA53440-4633-4CE8-97C8-38546ACE4755 Q35741610-DED097DA-4DE1-4114-ABD2-2336B0AF2277 Q35955244-7214D270-54DF-4887-9F7C-2B54E98EAE65 Q35993392-6B50CA8D-4817-4AC8-91FF-E7AFF07D504B Q36306149-FE485E99-7AA7-4FE4-889A-672B54D34423 Q36545609-EA6470EC-DC44-4FFA-9370-A0415B8B785D Q37096241-E339B269-BF9D-4A69-A213-E5EFE953042C Q37431430-82B25B82-9863-4760-928B-A78702E87A25 Q37710388-003F599E-070F-4A2F-B08A-24F6DD40EA94 Q37714160-9E55CF92-A464-4DDD-AFC2-F954EDFD4556 Q38221463-3D7ED3C9-1FC6-428A-A19C-3526C6E97458 Q38287688-899EDF6F-A664-4641-80F9-2145E9E6FC74 Q38349376-B5475F53-E5B4-4A93-BC2E-77B427BD069F Q38763790-56300130-E788-45C9-AA26-A7BD69960655 Q38840239-C83F5BE1-1F5B-45E2-BE2D-64D1D425E757 Q38868671-B9F99723-989B-4839-BC55-B38102CD5713 Q38880519-B83A6D5C-7FFC-482E-BB37-FD8EE5D1BEF6 Q38885475-6BF44772-9B8E-4F4B-820C-5DDC65BC4440 Q38952600-6CC78E40-83E6-4F01-A5DD-F290232E1906 Q38957643-1CE50670-A216-4209-B84D-84049F391FE7 Q38980793-CFBAE64F-1608-4DFA-8D0E-254060A77A51 Q40979559-B0AB21E7-2C21-4975-9385-3E07469DF23B Q41471175-B223448A-C034-435D-9EFC-4CF3583992FD Q42080797-3298FB21-B860-4224-87E6-5A0A5E62A96B Q42376186-2DDE1C2A-7563-4F17-9867-817DCF58A831 Q42755954-E59E3C99-4252-47A6-BDB4-04493CCCDA8E Q47240245-20F48DED-1F04-4D0A-B78D-D79E1768DCEB Q52618532-FC2F176F-209E-46F6-979C-746399CBAD4B Q52879747-E8EE040C-2B0A-4754-A6A8-BB1444542533 Q52936872-CCCD7613-4FF1-408F-B4C3-BA1A1B94D4A5 Q53692325-60E96FCB-35AA-4C04-989A-11F8AABB7F4A Q54354737-976C1AA4-4D92-4529-89F1-118BB11FA591 Q54940982-3D781859-782F-4624-89A5-9FE26CC1A69D

P2860

The Wnt signalling pathway is upregulated in an in vitro model of acquired tamoxifen resistant breast cancer.

http://www.wikidata.org/entity/Q34644859

description

2013 nî lūn-bûn

@nan

2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

The Wnt signalling pathway is ...... xifen resistant breast cancer.

@ast

The Wnt signalling pathway is ...... xifen resistant breast cancer.

@en

The Wnt signalling pathway is ...... xifen resistant breast cancer.

@nl

type

label

The Wnt signalling pathway is ...... xifen resistant breast cancer.

@ast

The Wnt signalling pathway is ...... xifen resistant breast cancer.

@en

The Wnt signalling pathway is ...... xifen resistant breast cancer.

@nl

prefLabel

The Wnt signalling pathway is ...... xifen resistant breast cancer.

@ast

The Wnt signalling pathway is ...... xifen resistant breast cancer.

@en

The Wnt signalling pathway is ...... xifen resistant breast cancer.

@nl

P1433

Q34644859-3F6BDB03-A564-4ED2-A511-11FDF27C61C6

P1476

Q34644859-F2B35E7A-3080-47DA-A151-2C0F06A335E2

P2093

Q34644859-43F61EBF-5687-491F-8455-46BBCBFFBE7A

Q34644859-48EAD2A8-A27A-4639-8A93-5BDB3FFE8670

Q34644859-63D46E76-0ECC-413F-A5BC-4C0FD7258740

Q34644859-B77F3571-8DCB-41B1-8331-807B2BABA4F1

P2860

Q34644859-078BAD06-0405-4D37-BDFF-B8C31F474553

Q34644859-08E03E72-F80E-4AF5-BDC3-7BA35FD583B8

Q34644859-0C7AE517-27D6-4356-A9AD-D492D4760F2F

Q34644859-1386A633-4FCA-4818-A285-A7B598A8F6F6

Q34644859-13940C0C-18B9-4D30-88C4-72C1C9CEBBE7

Q34644859-154FA3CD-A8FF-4204-B274-CDD477261F28

Q34644859-16B61F86-FB9B-4947-8185-5A2CFD67C862

Q34644859-19E49B4A-6309-42A3-9BB8-C3DE134539C1

Q34644859-1C26A680-FCA1-4457-BEAC-E9D69178C73B

Q34644859-1E13223A-25ED-414D-BE18-5F4F53C2EE0D

P2888

Q34644859-AFCF1715-7716-4F22-9023-613838727045

P304

Q34644859-259AEFEB-821A-4854-8131-BA3BD91E86D1

P31

Q34644859-B6E69CE4-EDFB-4BA2-B107-900751392CCE

P356

Q34644859-BC1306D1-ACD8-4E0B-839A-F9254061028D

P407

Q34644859-47BC4856-83F9-476D-BDF4-20774C9B47EA

P478

Q34644859-27976BBF-440B-439B-B5E7-A488A7B49EA7

P50

Q34644859-3DE89DCA-B18D-45F1-908F-82E35C2C16F5

Q34644859-B24AE4BA-616A-4BB0-B4D9-ED405FC6253A

P577

Q34644859-E5A63CD7-6BD2-4C33-AC78-6917CBBB1851

P5875

Q34644859-90B95C73-94F2-4463-AC82-62A21E6FAAAB

P6179

Q34644859-2EE7BEFF-F04C-4433-9939-4249C676C749

P698

Q34644859-D1A69757-FF24-425E-9317-A03B947055EF

P932

Q34644859-ED2203BF-1139-45BF-93AD-72B1823FECCF

P356

1471-2407-13-174

P1433

P1476

The Wnt signalling pathway is ...... xifen resistant breast cancer.

@en

P2093

Ellen L Hedditch

http://www.w3.org/2001/XMLSchema#string

Eve Jary

http://www.w3.org/2001/XMLSchema#string

Laura A Baker

http://www.w3.org/2001/XMLSchema#string

Yan Ni Loh

http://www.w3.org/2001/XMLSchema#string

P2860

Wnt/β-catenin signaling and disease

The dual role of the novel Wnt receptor tyrosine kinase, ROR2, in human carcinogenesis

Activation of the canonical Wnt/β-catenin pathway in ATF3-induced mammary tumors

Epithelial-mesenchymal transitions in development and disease

Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway.

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

WNT and beta-catenin signalling: diseases and therapies

Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer

c-Myc activates BRCA1 gene expression through distal promoter elements in breast cancer cells.

Cyclin D1 is not an immediate target of beta-catenin following Apc loss in the intestine.

P2888

1471-2407-13-174

P304

174

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-13-174

http://www.w3.org/2001/XMLSchema#string

P407

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-04-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236098816

http://www.w3.org/2001/XMLSchema#string

P6179

1038540860

http://www.w3.org/2001/XMLSchema#string

P698

23547709

http://www.w3.org/2001/XMLSchema#string

P932

3621642

http://www.w3.org/2001/XMLSchema#string